Defence Therapeutics Inc.
DTC
Classement en actions
#29781
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Prix de l'action
$0.24953854
Dernière synchronisation: 2026-10-16
Capitalisation boursière
$18.91M
Changement (1 jour)
-5.56%
Changement (1 an)
-53.23%
Pays
CA
Échange Defence Therapeutics Inc. (DTC)
Catégorie
Healthcare
Capitalisation boursière de Defence Therapeutics Inc.(DTC)
Capitalisation boursière: $18.91M
En October 2026, Defence Therapeutics Inc. a une capitalisation boursière de $18.91M. Cela fait de Defence Therapeutics Inc. la 29781st entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Defence Therapeutics Inc. du 2021 au 2026
DTC par rapport au top 5 des plus populaires stocks
| Prix pour DTC | L’actif B | La capitalisation boursière de B | Résultats | |
|---|---|---|---|---|
$68,177.37
$18.79M
|
$5.167T | +27,501,863.69% | ||
|
$66,168.34
$18.79M
|
$5.015T | +26,691,443.78% | ||
|
$54,209.00
$18.79M
|
$4.108T | +21,867,183.56% | ||
|
$51,484.32
$18.79M
|
$3.902T | +20,768,079.75% | ||
|
$35,486.47
$18.79M
|
$2.689T | +14,314,734.49% |
